A clinical investigator think tank and enduring multimedia
activity with Drs Naval Daver, Stephen Strickland, Geoffrey Uy and
Eunice Wang, including the following topics:
Introduction to therapy-related Acute Myeloid Leukemia (AML)
(0:00)
Treatment of AML evolving from prior MDS (12:27)
Treatment of secondary AML in a patient ineligible for
intensive therapy (29:41)
Treatment for a patient with secondary AML with an IDH mutation
(40:56)
Long-term follow-up of CPX- 351 in patients with secondary AML
(46:27)
Potential role of venetoclax in combination with intensive
chemotherapy regimens (52:54)
Treatment for younger patients with secondary AML (58:46)
Treatment of secondary AML with a FLT3 mutation (1:03:59)
Data with CPX-351 in combination with targeted agents
(1:08:30)
Refractory disease versus differentiation syndrome from IDH
inhibitors (1:19:20)
Emerging data with menin inhibitors (1:28:13)
Treatment of secondary AML evolving from prior MPN
(1:31:52)
Treatment of secondary AML with core binding factor
(1:53:14)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.